The Physical Health Care Fidelity Scale: Psychometric Properties

Torleif Ruud, Tordis Sørensen Høifødt, Delia Cimpean Hendrick, Robert E Drake, Anne Høye, Matthew Landers, Kristin S Heiervang, Gary R Bond, Torleif Ruud, Tordis Sørensen Høifødt, Delia Cimpean Hendrick, Robert E Drake, Anne Høye, Matthew Landers, Kristin S Heiervang, Gary R Bond

Abstract

Mental health programs need an instrument to monitor adherence to evidence-based physical health care for people with serious mental illness. The paper describes the Physical Health Care Fidelity Scale and study interrater reliability, frequency distribution, sensitivity to change and feasibility. Four fidelity assessments were conducted over 18 months at 13 sites randomized to implementation support for evidence-based physical health care. We found good to excellent interrater reliability, adequate sensitivity for change, good feasibility and wide variability in fidelity across sites after 18 months of implementation. Programs were more successful in establishing Policies stating physical health care standards than in implementing these Policies. The Physical Health Care Fidelity Scale measures and guides implementation of evidence-based physical health care reliably.Trial registration: ClinicalTrials.gov Identifier: NCT03271242.

Keywords: Evidence-based practice; Fidelity scale; Implementation; Physical health care; Psychoses.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Development of overall fidelity, and at Policies and Practices fidelity

References

    1. Ayerbe L, Forgnone I, Foguet-Boreu Q, Gonzalez E, Addo J, Ayis S. Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: A systematic review and meta-analysis. Psychological Medicine. 2018;48(16):2693–2701. doi: 10.1017/s0033291718000302.
    1. Banham L, Gilbody S. Smoking cessation in severe mental illness: What works? Addiction. 2010;105(7):1176–1189. doi: 10.1111/j.1360-0443.2010.02946.x.
    1. Barbui C, Girlanda F, Ay E, Cipriani A, Becker T, Koesters M. Implementation of treatment guidelines for specialist mental health care. Cochrane Database Systematic Review. 2014 doi: 10.1002/14651858.CD009780.pub2.
    1. Bond, G. R., Williams, J., Evans, L., Salyers, M., Kim, H. W., Sharpe, H., & Leff, H. S. (2000). Psychiatric rehabilitation fidelity toolkit. Cambridge, MA: Human Services Research Institute. Retrieved September 2, 2014 from .
    1. Chacón F, Mora F, Gervás-Ríos A, Gilaberte I. Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Annals of General Psychiatry. 2011;10(1):22. doi: 10.1186/1744-859x-10-22.
    1. Chandler DW. Fidelity and outcomes in six integrated dual disorders treatment programs. Community Mental Health Journal. 2011;47:82–89. doi: 10.1007/s10597-009-9245-0.
    1. Chang, C. K., Hayes, R. D., Perera, G., Broadbent, M. T., Fernandes, A. C., Lee, W. E.,..., Stewart, R. (2011). Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE, 6(5), e19590. 10.1371/journal.pone.0019590.
    1. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment. 1994;6(4):284–290. doi: 10.1037/1040-3590.6.4.284.
    1. Citrome L, Yeomans D. Do guidelines for severe mental illness promote physical health and well-being? Journal of Psychopharmacology. 2005;19(6 Suppl):102–109. doi: 10.1177/0269881105059505.
    1. Correll, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A.,..., Kane, J. M. (2014). Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders. JAMA Psychiatry, 71(12), 1350. 10.1001/jamapsychiatry.2014.1314.
    1. Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P.,..., Stubbs, B. (2017). Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry, 16(2), 163–180. 10.1002/wps.20420.
    1. Curtis J, Newall HD, Samaras K. The heart of the matter: Cardiometabolic care in youth with psychosis. Early Intervention in Psychiatry. 2012;6(3):347–353. doi: 10.1111/j.1751-7893.2011.00315.x.
    1. Dauwan M, Begemann MJH, Heringa SM, Sommer IE. Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia: A systematic review and meta-analysis. Schizophrenia Bulletin. 2016;42(3):588–599. doi: 10.1093/schbul/sbv164.
    1. De Hert, M., Correll, C. U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I.,..., Leucht, S. (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1), 52–77.
    1. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) European Psychiatry. 2009;24(6):412–424. doi: 10.1016/j.eurpsy.2009.01.005.
    1. Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychological Medicine. 2015;45(7):1343–1361. doi: 10.1017/s0033291714003110.
    1. Foguet-Boreu, Q., Fernandez San Martin, M. I., Flores Mateo, G., Zabaleta Del Olmo, E., Ayerbe Garcia-Morzon, L., Perez-Pinar Lopez, M.,..., Violan, C. (2016). Cardiovascular risk assessment in patients with a severe mental illness: A systematic review and meta-analysis. BMC Psychiatry, 16, 141. 10.1186/s12888-016-0833-6.
    1. Heiberg, I. H., Jacobsen, B. K., Nesvag, R., Bramness, J. G., Reichborn-Kjennerud, T., Naess, O.,..., Hoye, A. (2018). Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder. PLoS ONE, 13(8), e0202028. 10.1371/journal.pone.0202028.
    1. Hjorthoj C, Sturup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: A systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301. doi: 10.1016/s2215-0366(17)30078-0.
    1. Høifødt, T. S., & Høye, A. (2016). Toolkit for evidence-based physical health care (Verktøykasse for oppfølging av fysisk helse). Retrieved from Lørenskog, Norway.
    1. Jahagirdar, D., & Kaunelis, D. (2017). Smoking cessation interventions for patients with severe mental illnesses: A review of clinical effectiveness and guidelines. Retrieved June 15, 2019, from Ottawa, .
    1. Kahl KG. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Hormone Molecular Biology and Clinical Investigation. 2018 doi: 10.1515/hmbci-2018-0054.
    1. Khokhar MA, Khokhar WA, Clifton AV, Tosh GE. Oral health education (advice and training) for people with serious mental illness. Cochrane Database of Systematic Reviews. 2016 doi: 10.1002/14651858.CD008802.pub3.
    1. Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, Blow FC. Excess heart-disease-related mortality in a national study of patients with mental disorders: Identifying modifiable risk factors. General Hospital Psychiatry. 2009;31(6):555–563. doi: 10.1016/j.genhosppsych.2009.07.008.
    1. Kisely S, Baghaie H, Lalloo R, Johnson NW. Association between poor oral health and eating disorders: Systematic review and meta-analysis. British Journal of Psychiatry. 2015;207(4):299–305. doi: 10.1192/bjp.bp.114.156323.
    1. Kisely S, Baghaie H, Lalloo R, Siskind D, Johnson NW. A systematic review and meta-analysis of the association between poor oral health and severe mental illness. Psychosomatic Medicine. 2015;77(1):83–92. doi: 10.1097/psy.0000000000000135.
    1. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine. 2016;15(2):155–163. doi: 10.1016/j.jcm.2016.02.012.
    1. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Frontiers in Psychology. 2013;4:863. doi: 10.3389/fpsyg.2013.00863.
    1. Laursen TM, Mortensen PB, MacCabe JH, Cohen D, Gasse C. Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: A Danish population-based study. Psychological Medicine. 2014;44(8):1625–1637. doi: 10.1017/S003329171300216X.
    1. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. BMJ. 2013;346:f2539. doi: 10.1136/bmj.f2539.
    1. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychological Methods. 1996;1:30–46. doi: 10.1037/1082-989X.1.1.30.
    1. Mitchell AJ, Vancampfort D, De Hert M, Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. General Hospital Psychiatry. 2015;37(1):14–23. doi: 10.1016/j.genhosppsych.2014.11.006.
    1. Nordentoft, M., Wahlbeck, K., Hallgren, J., Westman, J., Osby, U., Alinaghizadeh, H.,..., Laursen, T. M. (2013). Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS ONE, 8(1), e55176. 10.1371/journal.pone.0055176.
    1. Osby U, Westman J, Hallgren J, Gissler M. Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010. European Journal of Public Health. 2016;26(5):867–871. doi: 10.1093/eurpub/ckv245.
    1. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry. 2007;64(10):1123–1131. doi: 10.1001/archpsyc.64.10.1123.
    1. Schober P, Boer C, Schwarte LA. Correlation coefficients: Appropriate use and interpretation. Anesthesia and Analgesia. 2018;126(5):1763–1768. doi: 10.1213/ANE.0000000000002864.
    1. Singh VK, Karmani S, Malo PK, Virupaksha HG, Muralidhar D, Venkatasubramanian G, Muralidharan K. Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: A meta-analysis. Schizophrenia Research. 2018;202:17–25. doi: 10.1016/j.schres.2018.06.066.
    1. Stubbs B, Vancampfort D, De Hert M, Mitchell AJ. The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: A systematic review and comparative meta-analysis. Acta Psychiatrica Scandinavica. 2015;132(2):144–157. doi: 10.1111/acps.12439.
    1. Tansella M, Thornicroft G. Implementation science: Understanding the translation of evidence into practice. British Journal of Psychiatry. 2009;195(4):283–285. doi: 10.1192/bjp.bp.109.065565.
    1. Teasdale SB, Ward PB, Rosenbaum S, Watkins A, Curtis J, Kalucy M, Samaras K. A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis. British Journal of Nutrition. 2016;115(11):1987–1993. doi: 10.1017/s0007114516001033.
    1. Tek C, Kucukgoncu S, Guloksuz S, Woods SW, Srihari VH, Annamalai A. Antipsychotic-induced weight gain in first-episode psychosis patients: A meta-analysis of differential effects of antipsychotic medications. Early Intervention in Psychiatry. 2016;10(3):193–202. doi: 10.1111/eip.12251.
    1. Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B.,..., Stubbs, B. (2016). Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: A systematic review and large scale meta-analysis. World Psychiatry, 15(2), 166–174. 10.1002/wps.20309.
    1. Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B.,..., Correll, C. U. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry, 14(3), 339–347. 10.1002/wps.20252.
    1. Weinmann S, Koesters M, Becker T. Effects of implementation of psychiatric guidelines on provider performance and patient outcome: Systematic review. Acta Psychiatrica Scandinavica. 2007;115(6):420–433. doi: 10.1111/j.1600-0447.2007.01016.x.
    1. Wey MC, Loh S, Doss JG, Abu Bakar AK, Kisely S. The oral health of people with chronic schizophrenia: A neglected public health burden. Australian and New Zealand Journal of Psychiatry. 2016;50(7):685–694. doi: 10.1177/0004867415615947.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj